Health Condition 1: 4- Measurement and Monitoring
Conditions
Interventions
Intervention1: INJ.Dexmedetomidine: INJ.Dexmedetomidine 0.3mcg/kg intravenous diluted to 20 ml with normal saline will be given over 10 min
Control Intervention1: NA: NA
Sponsors
Sapthagiri Institute Of Medical Sciences and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists Physical Status 1 Patient posted for elective surgeries under general anesthesia
Exclusion criteria
Exclusion criteria: Patient who were physically dependent on narcotics, those with a history of bronchial asthma, drug or alcohol abuse, known drug allergy to either clonidine or dexmedetomidine. Any predicted difficult airway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HR and NIBP are more stable following laryngoscopy and intubation with Inj.Dexmedetomidine 0.5%Timepoint: parameters recorded will be HR, SBP, DBP and MAP at 1, 3 and 5 min after intubation. | — |
Secondary
| Measure | Time frame |
|---|---|
| compare the adverse effect & complication of the drug & their doses like hypotension & bradycardia.Timepoint: During drug infusion hemodynamics monitoring for 10 minutes | — |
Countries
India
Contacts
Public ContactShruthi N S
Sapthagiri Institute of Medical Sciences and Research Centre
Outcome results
None listed